Serena Williams, the legendary 23-time Grand Slam champion, has publicly revealed that she turned to a GLP-1 type medication to lose 31 pounds after facing a difficult battle with her body following two pregnancies, noting that neither intensive training nor strict dieting allowed her to reach a healthy weight. The tennis star explained that she began the treatment in 2024 under medical supervision and with the support of the telemedicine platform Ro, for which she now serves as a spokesperson.
She added that since then she has experienced more energy, less joint pain, and a renewed sense of physical and mental lightness. Aware of the controversy surrounding the use of these medications, Williams emphasized that her decision was neither a shortcut nor a frivolity, but a medical solution to a real need. She affirmed that every person must learn to love themselves regardless of size or appearance, but that it is also valid to seek professional help to improve one’s health.
The revelation has sparked divided opinions in the public sphere. While some critics argue that it is inappropriate for such an influential figure to promote weight-loss drugs, others praise her candor and the courage to share an intimate experience that highlights the challenges of motherhood and physical recovery. Williams, who no longer competes professionally, remains one of the most recognized athletes in the world. Her testimony once again reopens the debate about the role of science, social pressure, and personal acceptance in shaping women’s bodies, especially for public figures subjected to constant scrutiny.
